Casey C. Kopczynski

2021

In 2021, Casey C. Kopczynski earned a total compensation of $1.5M as Chief Innovation Officer, Head of Research and External Innovation at Aerie Pharmaceuticals, a 2% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$220,050
Option Awards$583,500
Salary$457,010
Stock Awards$194,040
Other$7,998
Total$1,462,598

Kopczynski received $583.5K in option awards, accounting for 40% of the total pay in 2021.

Kopczynski also received $220.1K in non-equity incentive plan, $457K in salary, $194K in stock awards and $8K in other compensation.

Rankings

In 2021, Casey C. Kopczynski's compensation ranked 7,354th out of 12,405 executives tracked by ExecPay. In other words, Kopczynski earned more than 40.7% of executives.

ClassificationRankingPercentile
All
7,354
out of 12,405
41st
Division
Manufacturing
3,229
out of 5,494
41st
Major group
Chemicals And Allied Products
1,430
out of 2,369
40th
Industry group
Drugs
1,273
out of 2,090
39th
Industry
Biological Products, Except Diagnostic Substances
295
out of 452
35th
Source: SEC filing on April 26, 2022.

Kopczynski's colleagues

We found seven more compensation records of executives who worked with Casey C. Kopczynski at Aerie Pharmaceuticals in 2021.

2021

Vicente Anido

Aerie Pharmaceuticals

Chief Executive Officer

2021

Raj Kannan

Aerie Pharmaceuticals

Chief Executive Officer

2021

Thomas Mitro

Aerie Pharmaceuticals

Chief Operating Officer

2021

John LaRocca

Aerie Pharmaceuticals

General Counsel

2021

Benjamin McGraw

Aerie Pharmaceuticals

Former Interim Executive Chair

2021

Richard Rubino

Aerie Pharmaceuticals

Chief Financial Officer

2021

Christopher Staten

Aerie Pharmaceuticals

Chief Financial Officer

News

You may also like